We narrowed to 64 results for: HAL;

1. pAAV-double floxed-eNpHR-EYFP-WPRE-pA (AAV9)

   Viral Prep

   #20949-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-double floxed-eNpHR-EYFP-WPRE-pA (#20949). In addition to the viral particles, you will also receive purified pAAV-double floxed-eNpHR-EYFP-WPRE-pA plasmid DNA. EF1a-driven, cre-dependent eNpHR EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Promoter

   EF1a

   Tags

   EYFP (Cre-dependent)

   Available Since

   July 12, 2018

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (AAV5)

   Viral Prep

   #84446-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (#84446). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] plasmid DNA. CAG-driven, Cre-dependent expression of Jaws-KGC-tdTomato-ER2 for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Available Since

   June 26, 2024

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (AAV1)

   Viral Prep

   #84445-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (#84445). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] plasmid DNA. CAG-driven, Cre-dependent Jaws-GFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Tags

   GFP (Cre-dependent)

   Available Since

   Aug. 24, 2020

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (AAV1)

   Viral Prep

   #84446-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (#84446). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] plasmid DNA. CAG-driven, Cre-dependent expression of Jaws-KGC-tdTomato-ER2 for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Tags

   tdTomato

   Available Since

   March 18, 2024

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (AAV5)

   Viral Prep

   #84445-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (#84445). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] plasmid DNA. CAG-driven, Cre-dependent Jaws-GFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Tags

   GFP (Cre-dependent)

   Available Since

   Oct. 10, 2018

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (AAV8)

   Viral Prep

   #84446-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] (#84446). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-tdTomato-ER2] plasmid DNA. CAG-driven, Cre-dependent expression of Jaws-KGC-tdTomato-ER2 for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Available Since

   June 21, 2024

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (AAV Retrograde)

   Viral Prep

   #84445-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] (#84445). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-rc [Jaws-KGC-GFP-ER2] plasmid DNA. CAG-drive, Cre-dependent Jaws-GFP for optogenetic inhibition. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Chuong et al Nat Neurosci. 2014 Aug;17(8):1123-9. doi

   Promoter

   CAG

   Tags

   GFP (Cre-dependent)

   Available Since

   Oct. 12, 2017

   Availability

   Academic Institutions and Nonprofits only

8. lentiCas9-Blast (Lentiviral Prep)

   Viral Prep

   #52962-LV

   Purpose

   Ready-to-use Lentiviral Prep particles produced from lentiCas9-Blast (#52962). In addition to the viral particles, you will also receive purified lentiCas9-Blast plasmid DNA. Lentiviral particles carrying Cas9 and blasticidin resistance. This virus is used to make stable cell lines expressing Cas9.

   Depositor

   Feng Zhang

   Article

   Sanjana et al Nat Methods. 2014 Aug;11(8):783-4. doi:

   Promoter

   EFS-NS

   Available Since

   July 14, 2016

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-Ef1a-DIO ChETA-EYFP (AAV5)

   Viral Prep

   #26968-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-Ef1a-DIO ChETA-EYFP (#26968). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO ChETA-EYFP plasmid DNA. EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Gunaydin et al Nat Neurosci. 2010 Mar;13(3):387-92. doi

   Promoter

   EF1a

   Tags

   EYFP (Cre-dependent)

   Available Since

   Feb. 20, 2018

   Availability

   Academic Institutions and Nonprofits only

10. pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (AAV5)

    Viral Prep

    #121539-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (#121539). In addition to the viral particles, you will also receive purified pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) plasmid DNA. Synapsin-driven, HA-tagged hM3D(Gq) for neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Christopher Richie

    Article

    Galvan et al Eur J Neurosci. 2019 May 7. doi: 10.1111

    Promoter

    Syn

    Tags

    HA

    Available Since

    Feb. 21, 2019

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-Ef1a-DIO ChETA-EYFP (AAV9)

    Viral Prep

    #26968-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-Ef1a-DIO ChETA-EYFP (#26968). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO ChETA-EYFP plasmid DNA. EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Gunaydin et al Nat Neurosci. 2010 Mar;13(3):387-92. doi

    Promoter

    EF1a

    Tags

    EYFP (Cre-dependent)

    Available Since

    March 30, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) (AAV5)

    Viral Prep

    #121538-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) (#121538). In addition to the viral particles, you will also receive purified pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) plasmid DNA. Synapsin-driven, HA-tagged hM4D(Gi) for neuronal inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Christopher Richie

    Article

    Galvan et al Eur J Neurosci. 2019 May 7. doi: 10.1111

    Promoter

    Syn

    Tags

    HA

    Available Since

    March 26, 2019

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-Ef1a-DIO ChETA-EYFP (AAV1)

    Viral Prep

    #26968-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO ChETA-EYFP (#26968). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO ChETA-EYFP plasmid DNA. EF1a-driven, Cre-dependent, ChETA fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Gunaydin et al Nat Neurosci. 2010 Mar;13(3):387-92. doi

    Promoter

    EF1a

    Tags

    EYFP (Cre-dependent)

    Available Since

    Feb. 21, 2018

    Availability

    Academic Institutions and Nonprofits only

14. pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (AAV Retrograde)

    Viral Prep

    #121539-AAVrg

    Purpose

    Ready-to-use AAV Retrograde particles produced from pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (#121539). In addition to the viral particles, you will also receive purified pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) plasmid DNA. Synapsin-driven, HA-tagged hM3D(Gq) for neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Christopher Richie

    Article

    Galvan et al Eur J Neurosci. 2019 May 7. doi: 10.1111

    Promoter

    Syn

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

15. pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (AAV2)

    Viral Prep

    #121539-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) (#121539). In addition to the viral particles, you will also receive purified pOTTC1596 - pAAV SYN1 HA-hM3D(Gq) plasmid DNA. Synapsin-driven, HA-tagged hM3D(Gq) for neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Christopher Richie

    Article

    Galvan et al Eur J Neurosci. 2019 May 7. doi: 10.1111

    Promoter

    Syn

    Tags

    HA

    Available Since

    April 3, 2023

    Availability

    Academic Institutions and Nonprofits only

16. pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) (AAV2)

    Viral Prep

    #121538-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) (#121538). In addition to the viral particles, you will also receive purified pOTTC1484 - pAAV SYN1 HA-hM4D(Gi) plasmid DNA. Synapsin-driven, HA-tagged hM4D(Gi) for neuronal inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Christopher Richie

    Article

    Galvan et al Eur J Neurosci. 2019 May 7. doi: 10.1111

    Promoter

    Syn

    Tags

    HA

    Available Since

    Sept. 25, 2019

    Availability

    Academic Institutions and Nonprofits only

17. pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV8)

    Viral Prep

    #61592-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Feng Zhang

    Article

    Ran et al Nature. 2015 Apr 1. doi: 10.1038/nature1

    Available Since

    Sept. 22, 2025

    Availability

    Academic Institutions and Nonprofits only

18. pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (AAV6)

    Viral Prep

    #61592-AAV6

    Purpose

    Ready-to-use AAV6 particles produced from pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA (#61592). In addition to the viral particles, you will also receive purified pX600-AAV-CMV::NLS-SaCas9-NLS-3xHA-bGHpA plasmid DNA. CMV-driven expression of SaCas9. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Feng Zhang

    Article

    Ran et al Nature. 2015 Apr 1. doi: 10.1038/nature1

    Available Since

    July 16, 2025

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (AAV9)

    Viral Prep

    #35499-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP (#35499). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-C1V1 (t/t)-TS-EYFP plasmid DNA. CaMKIIa-driven, C1V1 (t/t) fused to EYFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Article

    Yizhar et al Nature. 2011 Jul 27;477(7363):171-8. doi

    Promoter

    CaMKII

    Tags

    EYFP

    Available Since

    April 6, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-flex-taCasp3-TEVp (AAV5)

    Viral Prep

    #45580-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-flex-taCasp3-TEVp (#45580). In addition to the viral particles, you will also receive purified pAAV-flex-taCasp3-TEVp plasmid DNA. EF1a-driven, Cre-dependent, bicicstronic expression of designer pro-taCasp3 and TEVp. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Nirao Shah, Jim Wells

    Article

    Yang et al Cell. 2013 May 9;153(4):896-909. doi: 10

    Promoter

    EF1a

    Available Since

    Sept. 25, 2020

    Availability

    Academic Institutions and Nonprofits only